Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition-Reference-Cited by-同舟云学术

Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition

Published:2010-09-30 Issue:11 Volume:133 Page:3166-3180
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Geis Christian,Weishaupt Andreas,Hallermann Stefan,Grünewald Benedikt,Wessig Carsten,Wultsch Thomas,Reif Andreas,Byts Nadiya,Beck Marcus,Jablonka Sibylle,Boettger Michael K.,Üçeyler Nurcan,Fouquet Wernher,Gerlach Manfred,Meinck Hans-Michael,Sirén Anna-Leena,Sigrist Stephan J.,Toyka Klaus V.,Heckmann Manfred,Sommer Claudia

Publisher

Oxford University Press (OUP)

Subject

Clinical Neurology

Link

http://academic.oup.com/brain/article-pdf/133/11/3166/16695367/awq253.pdf

Reference61 articles.

1. The interpretation of potential changes in the spinal cord;Barron;J Physiol,1938

2. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica;Bennett;Ann Neurol,2009

3. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo;Bradl;Ann Neurol,2009

4. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins;Buchwald;Muscle Nerve,2005

5. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barre syndrome: a macro-patch-clamp study;Buchwald;Ann Neurol,1998

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Intravenous Cyclophosphamide in a Patient With Anti-amphiphysin Autoimmunity Presenting With Bulbar Palsy and Cerebellar Ataxia: A Case Report;Cureus;2024-07-25

2. Autoantibody Mediated Diseases of the Central Nervous System;Reference Module in Life Sciences;2024

3. Pathogenesis and immunopathology of paraneoplastic disorders;Handbook of Clinical Neurology;2024

4. Stiff-Person Syndrome Spectrum Disorders;Neuroimmune Diseases;2024

5. Paraneoplastic Neurological Syndromes;Neuroimmune Diseases;2024